Quantcast

Latest Neurofibrillary tangle Stories

2010-07-13 12:30:00

- Two Target Tau; Two May Reduce Tau Though Their Target Was Amyloid - HONOLULU, July 13 /PRNewswire-USNewswire/ -- The primary therapeutic target in Alzheimer's disease has been the beta amyloid peptide, which clusters outside cells in the brain to form sticky clumps known as plaques.

2010-01-15 17:50:53

TGen-led team finds 3 proteins that dismantle 'bridges' within brain cells.

2009-11-11 18:05:06

Protein reduces levels of amyloid beta and tau hyperphosphorylation, 2 hallmarks of Alzheimer's.

2009-11-11 17:52:19

A new study reveals that a previously undiscovered mouse gene reduces the two major pathological perturbations commonly associated with Alzheimer's disease (AD).

2009-07-15 08:12:50

New insights into how a Phase III Alzheimer's drug might work were among the advances in potential therapies targeting two abnormal brain proteins – beta amyloid and phosphorylated tau – that were reported today at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna.

2009-07-15 01:30:00

VIENNA, July 15 /PRNewswire-USNewswire/ -- New insights into how a Phase III Alzheimer's drug might work were among the advances in potential therapies targeting two abnormal brain proteins - beta amyloid and phosphorylated tau - that were reported today at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna.

123464959aa2cc84ed9e6474920e234b1
2009-06-08 11:15:00

New research has shown that a rogue protein thought to cause Alzheimer's can spread through the brain, turning healthy tissue bad.

2009-05-05 08:53:43

Rare genetic disorder may benefit from development of new dementia treatments.

2009-02-06 08:54:59

Scientists at UC Santa Barbara have discovered that a protein called BAG2 is important for understanding Alzheimer's disease and may open up new targets for drug discovery.

2008-08-08 09:00:28

ProteoTech has completed regulatory investigational new drug requirements and has received clearance from the FDA to initiate its Phase I human clinical trial on Exebryl-1, a small molecule drug targeting toxic beta-amyloid protein accumulation for the treatment of Alzheimer's disease.


Word of the Day
quilisma
  • In medieval musical notation, a sign or neume denoting a shake or trill.
The word 'quilisma' comes from a Greek word meaning 'a roll'.